Expanded Access Protocol - Blinatumomab in Pediatric & Adolescent Subjects With Relapsed/Refractory B-precursor ALL
Clinical trial NCT02187354 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT02187354
- Sponsor
- Amgen
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.